2023-02-01 2024-01-31 false Capium Accounts Production 1.1 SC721526 2023-02-01 2024-01-31 SC721526 bus:FullAccounts 2023-02-01 2024-01-31 SC721526 bus:FRS102 2023-02-01 2024-01-31 SC721526 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 SC721526 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 SC721526 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 SC721526 2023-02-01 2024-01-31 SC721526 2024-01-31 SC721526 bus:RegisteredOffice 2023-02-01 2024-01-31 SC721526 core:WithinOneYear 2024-01-31 SC721526 core:AfterOneYear 2024-01-31 SC721526 1 2023-02-01 2024-01-31 SC721526 bus:Director1 2023-02-01 2024-01-31 SC721526 bus:Director1 2024-01-31 SC721526 bus:Director1 2022-02-01 2023-01-31 SC721526 2022-02-01 SC721526 bus:LeadAgentIfApplicable 2023-02-01 2024-01-31 SC721526 2022-02-01 2023-01-31 SC721526 2023-01-31 SC721526 core:WithinOneYear 2023-01-31 SC721526 core:AfterOneYear 2023-01-31 SC721526 bus:EntityAccountantsOrAuditors 2022-02-01 2023-01-31 SC721526 core:MotorCars 2023-02-01 2024-01-31 SC721526 core:MotorCars 2024-01-31 SC721526 core:MotorCars 2023-01-31 SC721526 core:FurnitureFittings 2023-02-01 2024-01-31 SC721526 core:FurnitureFittings 2024-01-31 SC721526 core:FurnitureFittings 2023-01-31 SC721526 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-01-31 SC721526 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-01-31 SC721526 core:CostValuation core:Non-currentFinancialInstruments 2024-01-31 SC721526 core:CostValuation core:Non-currentFinancialInstruments 2023-01-31 SC721526 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-01-31 SC721526 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-01-31 SC721526 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-01-31 SC721526 core:Non-currentFinancialInstruments 2024-01-31 SC721526 core:Non-currentFinancialInstruments 2023-01-31 SC721526 core:RetainedEarningsAccumulatedLosses 2024-01-31 SC721526 core:RetainedEarningsAccumulatedLosses 2023-01-31 SC721526 dpl:Item1 2023-02-01 SC721526 dpl:Item1 2024-01-31 SC721526 dpl:Item1 2022-02-01 SC721526 dpl:Item1 2023-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: SC721526
Scotland

 

 

 

SKYLARK EVENT MEDICAL SERVICES LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 February 2023

End date: 31 January 2024
Director J Peffers
Registered Number SC721526
Registered Office 27 St Johns Drive
Dunfermline
KY12 7TB
Accountants M & S Accountancy and Taxation Limited
Unit 26, Dunfermline Business Centre
Izatt Avenue
Dunfermline
Fife
KY11 3BZ
1
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 13,881    4,664 
13,881    4,664 
Current assets      
Stocks 4 8,000   
Debtors 5 615    9,006 
Cash at bank and in hand 1,582    32,239 
10,197    41,245 
Creditors: amount falling due within one year 6 (12,844)   (10,168)
Net current assets (2,647)   31,077 
 
Total assets less current liabilities 11,234    35,741 
Net assets 11,234    35,741 
 

Capital and reserves
     
Profit and loss account 11,234    35,741 
Shareholders' funds 11,234    35,741 
 


For the year ended 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 06 August 2025 and were signed by:


-------------------------------
J Peffers
Director
2
General Information
Skylark Event Medical Services Ltd is a private company, limited by shares, registered in Scotland, registration number SC721526, registration address 27 St Johns Drive, Dunfermline, KY12 7TB.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of medical services supplied by the company, net of VAT and trade discounts. Turnover is recognised on the accruals basis.
Taxation
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The companys liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles 25% Reducing Balance
Fixtures and Fittings 25% Reducing Balance
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Financial instruments
The company has elected to apply the provisions of Section 11 Basic Financial Instruments and Section 12 Other Financial Instruments Issues of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.

Average number of employees

Average number of employees during the year was 1 (2023 : 1).
3.

Tangible fixed assets

Cost or valuation Motor Vehicles   Fixtures and Fittings   Total
  £   £   £
At 01 February 2023 6,000    219    6,219 
Additions 13,863      13,863 
Disposals    
At 31 January 2024 19,863    219    20,082 
Depreciation
At 01 February 2023 1,500    55    1,555 
Charge for year 4,591    55    4,646 
On disposals    
At 31 January 2024 6,091    110    6,201 
Net book values
Closing balance as at 31 January 2024 13,772    109    13,881 
Opening balance as at 01 February 2023 4,500    164    4,664 


4.

Stocks

2024
£
  2023
£
Stocks 8,000   
8,000   

5.

Debtors: amounts falling due within one year

2024
£
  2023
£
Trade Debtors 9,300   
Provision for Doubtful Debts (9,300)  
Prepayments & Accrued Income 615   
Directors' Current Accounts   9,006 
615    9,006 

6.

Creditors: amount falling due within one year

2024
£
  2023
£
Corporation Tax 8,645    8,669 
Accrued Expenses 3,479    1,499 
Directors' Current Accounts 720   
12,844    10,168 

7.

Members' Liability

The members of Skylark Medical Services Ltd have undertaken to contribute a sum not exceeding £1 each to meet the liabilities of the company if it should be wound up.
8.

Reporting period length

The company was incorporated on 31 January 2022 and as such this is the second reporting period of the company, however the first comprising of a year. The previous reporting period covered twelve months and one day as such the figures are not directly comparable.
3